CANNFORMATICS
Developing saliva-based Cannabis-Responsive™ biomarkers to deliver predictable and repeatable science-based outcomes to improve health and quality of life.
CANNFORMATICS
Industry:
Bioinformatics Biotechnology Cannabis Health Care Wellness
Founded:
2017-08-28
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.cannformatics.com
Total Employee:
1+
Status:
Active
Contact:
415-742-8788
Email Addresses:
[email protected]
Total Funding:
100 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro Wix Shutterstock
Similar Organizations
Acrovirt
biotechnology
Atlas Origin
Biotechnology
AVD (Advanced Vapor Devices)
Vaporizer Technology
BoobyBiome
Biotechnology
Evive Biotech
Biotechnology
Initio
Biomedical Technology
Intrinsyx Research Corporation
Biotechnology
KDS Medical Engineering
Biotechnology Startup
Napigen
NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.
NUfloss
Biotechnology, Mobile App, Oral Health
Oxford Immune Algorithmics
Biotech
rBIO
Biotechnology
Revela Health
Biotechnology, Consumer Packaged Goods
Selectrion
Biotechnologie
Current Employees Featured
Founder
Investors List
Tom Vorisek
Tom Vorisek investment in Seed Round - Cannformatics
Official Site Inspections
http://www.cannformatics.com Semrush global rank: 5.38 M Semrush visits lastest month: 1.56 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Cannformatics"
Cannformatics Medical Cannabis Biotechnology
Cannformatics Publishes Third Paper Revealing Progress Towards Personalizing Medical Cannabis Treatment for ASD and other Neurological and Neuropyschiatric Disorders in Nature's Scientific Reports.See details»
Cannformatics - Crunchbase Company Profile & Funding
Cannformatics is a biotechnology company that personalizes medical cannabis treatment. Developing saliva-based Cannabis-Responsive™ biomarkers to …See details»
Cannformatics Details
Cannformatics is a medical cannabis biotechnology company dedicated to identifying and applying cannabis-responsive biomarkers to enhance health and quality of life.See details»
Cannformatics - Products, Competitors, Financials, Employees ...
About Cannformatics Cannformatics operates as a biotechnology company. The company's main service involves using proprietary technology to measure metabolic biomarkers, which helps to …See details»
Cannformatics - LinkedIn
Cannformatics | 284 followers on LinkedIn. Personalized Medical Cannabis Treatment | A bioinformatics platform that evaluates the physiological condition of the consumer to indicate …See details»
Cannformatics 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Cannformatics. Use the PitchBook Platform to explore the full profile.See details»
Kenneth Epstein, Cannformatics - Cannabis Business Times
Kenneth Epstein, Cannformatics Kenneth Epstein is the co-founder and Chief Commercial Officer of Cannformatics, a biotechnology start-up developing and applying Cannabis-Responsive™ …See details»
Cannformatics - Overview, News & Similar companies
View Cannformatics (www.cannformatics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Cannformatics - 2025 Company Profile & Competitors - Tracxn
Apr 26, 2025 Cannformatics is an unfunded company based in San Francisco (United States), founded in 2017 by Robert McKee, Itzhak Kurek and Kenneth Epstein. It operates as a …See details»
Our Team - Cannformatics
At Cannformatics, he provides project leadership for strategic partnerships and leadership on computational biology and computational chemistry. He has been a project management …See details»
Cannformatics Unlocks Medical Cannabis' Mechanism of Action in …
Mar 29, 2022 Cannformatics is an early-stage biotechnology startup focused on the development of Cannabis-Responsive™ biomarkers found in saliva for personalized medical …See details»
Cannformatics Information - RocketReach
Cannformatics is a Pharmaceutical Manufacturing company located in San Francisco, California with 5 employees. Find top employees, contact details and business statistics at RocketReach.See details»
FAQs | Cannformatics
Cannformatics spent over three-years in research and development developing and implementing its technology and methodologies with a multi-disciplinary team of experts in biochemistry, …See details»
Cannformatics - Funding, Financials, Valuation & Investors
Cannformatics is a biotechnology company that personalizes medical cannabis treatment.See details»
Cannformatics - startuphub.ai
Cannformatics, founded in 2017, is a bioinformatics platform that evaluates the physiological condition of the consumer to indicate the best fit cultivar and ensure a reproducible dosage.See details»
Cannformatics : and Cannabotech Announce the First Clinical …
Aug 17, 2021 SAN FRANCISCO and HERZLIYA, Israel, Aug. 17, 2021 /PRNewswire/ -- Cannformatics, an early-stage biotechnology startup focused on the identification and …See details»
Cannformatics Medical Cannabis Biotechnology
Our bioinformatics platform guides you to the best-fit available medical cannabis treatment, optimizing products, dosage and consumption methods to meet your wellness needs and …See details»
Cannformatics - Contacts, Employees, Board Members, Advisors
Cannformatics is a biotechnology company that personalizes medical cannabis treatment.See details»
Newsroom - Cannformatics
Aug 24, 2023 Cannformatics Strengthens Its Advisory Board with Appointment of Medical Cannabis Expert and Physician Bonni Goldstein, M.D. Nationally recognized medical cannabis …See details»
Cannformatics - Updates, News, Events, Signals & Triggers
Cannformatics may be growing as the company is mentioned in the context of an increasing trend in the treatment of children and adolescents with ASD using MC, which suggests a rising …See details»